Latest Research

A microfluidic approach for studying integrin αIIbβ3 activation and clustering

“Platelet adhesion and activation are mediated by integrin αIIbβ3 clustering, which is crucial for the hemostatic function of platelets. In an activated state, integrins provide the connection between the extracellular matrix and the actin cytoskeleton through a variety of cytoplasmic proteins, such as talin. Here, droplet-based microfluidics is applied to generate cell-sized giant unilamellar vesicles (GUVs) with a defined molecular composition to quantify the adhesion of integrin αIIbβ3-containing protocells in relation to the number of integrin–talin head domain (THD) complexes. Furthermore, it is shown that THD induces integrin clustering in protocells adhering to fibrinogen. The formation of this molecular link, which has, so far, only been observed in vivo, is an essential step in synthetic cell design to recapitulate integrin-mediated bidirectional signaling across the membrane. These results pave the way for further quantitative investigations of protein–protein interactions between integrins and associated proteins and their assembly within such defined, but complex, synthetic cells. An essential future step to mimic the complex interaction between cells and their environment will be to combine synthetic approaches with peptide chemistry to guide the molecular mechanisms involved in integrin binding and activation.

“Formation and adhesion of protocells containing integrin and THD. a) Schematic depiction of the formation of functional cell-sized liposomes that contain integrin and THD by droplet-based microfluidics. Scale bar: 50 μm. I) Encapsulation of bare liposomes (≈100 nm diameter), integrin-reconstituted proteoliposomes, and THD at defined concentration into microfluidic water-in-oil droplets of 30 μm diameter. II) Liposomes rupture at the droplets’ inner interface, fuse, and form a continuous lipid bilayer, the dsGUV. III) After the addition of destabilizing surfactant, the GUV is released from the stabilizing oil phase into an aqueous phase, i.e., an appropriate buffer solution. IV) Free-standing GUV that contains integrin and THD of defined concentrations, after its release. V) Released GUV adhering to a fibrinogen-coated surface as a result of integrin-activation by THD. Depiction not to scale. b) 3D-reconstitutions of integrin-containing protocells (lipid: ATTO488 (green), integrin: Alexa568 (red)). The images show increasing adhesion to fibrinogen-coated surfaces in correlation to an initially provided THD concentration of: I) 2 nM, II) 10 nM, III) 30 nM, IV) 80 nM, V) 200 nM at a constant integrin concentration. The spreading value of each vesicle shown is close to the mean value obtained from a corresponding sample of vesicles. For correlating data refer to Table 1. Scale bar: 10 μm. c) Integrin-clustering in the contact area of protocells adhering to fibrinogen-coated surfaces. The lipid composition of the protocells is 18:72:10 DOTAP:DOPC:Egg PC with reconstituted integrin (Alexa568) activated by: I) 1 mM Mn2+/1 mM Mg2+ (vesicle diameter: 12 μm) and II) 200 nM THD (vesicle diameter: 14 μm). The difference in the overall signal and concentration of clusters can be due to bleaching effects. Scale bar: 3 μm”. Reproduced under Creative Commons Attribution 4.0 International License from Benk, L.T., Benk, A.S., Lira, R.B., Cavalcanti-Adam, E.A., Dimova, R., Lipowsky, R., Geiger, B. and Spatz, J.P. (2022), Integrin αIIbβ3 Activation and Clustering in Minimal Synthetic Cells. Adv. NanoBiomed Res. 2100094.

 

Figures and the abstract are reproduced from Benk, L.T., Benk, A.S., Lira, R.B., Cavalcanti-Adam, E.A., Dimova, R., Lipowsky, R., Geiger, B. and Spatz, J.P. (2022), Integrin αIIbβ3 Activation and Clustering in Minimal Synthetic Cells. Adv. NanoBiomed Res. 2100094. https://doi.org/10.1002/anbr.202100094 under Creative Commons Attribution 4.0 International License


Read the original article:
Integrin αIIbβ3 Activation and Clustering in Minimal Synthetic Cells

Pouriya Bayat

Published by
Pouriya Bayat

Recent Posts

Microfluidic Chemiluminescence Platform for Embryo Implantation Prediction

Assessing which embryos have the highest chance of successful implantation remains a major challenge in…

March 19, 2026

A Micro-Organ Based Microfluidic Biosensor for Continuous Glucose Monitoring

Continuous glucose monitoring plays a central role in diabetes management, especially for patients with type…

March 9, 2026

Microfluidic Platform for Automated Organoid Culture and Longitudinal Imaging

Organoids have transformed in vitro tissue modeling, but their culture remains labor-intensive and variable. Manual…

February 28, 2026

Microfluidics for Integrated Spatial Transcriptomics and Protein Imaging on the Same Tissue Section

Spatial biology increasingly depends on technologies that can map gene expression and protein localization directly…

February 11, 2026

Microfluidic confinement reveals how bacteria cross one-micrometer-wide passages by flagellar wrapping

Microfluidic devices are widely used to replicate the physical constraints bacteria experience in natural and…

February 3, 2026

What Are Microfluidic Chips and Why They Matter in Canada

Microfluidic technology is changing how scientists work. It allows labs to run complex experiments using…

January 26, 2026